Dymedso is a Canadian-based pioneer of the airway clearance device industry for treatment of patients with Cystic Fibrosis (CF) and other respiratory conditions. With our unique patented technology, our company is committed to improving patient care while helping to save lives. Our team has spent the last several years demonstrating the effectiveness of our device for treating patients with critical lung conditions.

Our device, the Frequencer®, provides gentle, non-invasive airway clearance treatment via proprietary acoustic sound waves that match the resonance frequency of the lung’s mucus. These sound waves cause the lungs to vibrate, changing the viscosity of the mucus, dislodging it, and ultimately unblocking the airways, allowing the patient the capacity to better fight the infection. It is approved for use by Health Canada, the US Food and Drug Administration, and the European Community. The airway clearance that is available through our unique device has been demonstrated to be essential for treating the symptoms of pneumonia and acute respiratory distress (ARDS), which are also complications found in severe cases of COVID-19 patients.